The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b/2 KEYNOTE-365 cohort I: Pembrolizumab (pembro) plus carboplatin and etoposide chemotherapy (chemo) or chemo alone for metastatic neuroendocrine prostate cancer (NEPC).
 
Gunhild Von Amsberg
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; MSD; Pfizer; Roche Pharma AG
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Gilead Sciences; Ipsen; Janssen; Merck; Merck Serono; MSD Oncology; Pfizer; Roche
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AvenCell (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Ipsen (Inst); Lilly (Inst); MSD Oncology (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Merck Serono; Pfizer/EMD Serono; Roche
 
Urban Emmenegger
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer; Tersera
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Janssen; Knight Therapeutics; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer; Tersera
Research Funding - Astellas Pharma; Bayer; Janssen
 
Debbie Robbrecht
Honoraria - Springer
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Axiom Healthcare Strategies; BMS; Gilead Sciences (Inst); J&J (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Pfizer (Inst)
Research Funding - Merck KGaA (Inst)
 
Cagatay Arslan
Consulting or Advisory Role - Novartis, Merck, Astra Zeneca, Johnson &Johnson, Teva, Astellas, BMS, Amgen, Bayer
Speakers' Bureau - Novartis, Merck, Astra Zeneca, Johnson &Johnson, Teva, Astellas, BMS, Amgen, Bayer
Research Funding - Roche, Novartis, BMS, Merck, MSD, Astra Zeneca, Nektar, Johnson &Johnson, Lilly, Amgen, Incyte, Bayer, Yuhan, Henlius, Pfizer, Biontech, Genmab, Beigene, GSK
 
Niven Mehra
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag; MSD Oncology (Inst); Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca/Merck (Inst); Bristol Myers Squibb Foundation (Inst); Janssen-Cilag (Inst)
 
Enrique Gonzalez-Billalabeitia
Consulting or Advisory Role - AstraZeneca; Bayer; Janssen Oncology
Research Funding - AstraZeneca; Merck
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Janssen-Cilag; Pfizer; Pfizer; Roche; Sanofi
 
Mariusz Kwiatkowski
No Relationships to Disclose
 
Margitta Retz
No Relationships to Disclose
 
Fatih Köse
Honoraria - Astellas Pharma (Inst); AstraZeneca (Inst); Deva (Inst); GlaxoSmithKline (Inst); Janssen (Inst); MSD/Merck (Inst); Nobelpharma (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Deva; GlaxoSmithKline; Janssen; MSD/Merck; Nobelpharma; Novartis; Pfizer; Roche; Takeda
 
Mark Linch
Consulting or Advisory Role - ADC Therapeutics; Astellas Pharma; AstraZeneca; Bicycle Therapeutics; BioNTech; Bristol-Myers Squibb; Janssen Oncology; Merck Serono; Pfizer/EMD Serono
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Shionogi (Inst)
Travel, Accommodations, Expenses - bristol myers squibb; Janssen; Merck; MSD
 
Brigitte Laguerre
Honoraria - Astellas Pharma; Astellas Pharma; Bayer; Bayer; Bayer; Bayer; Bayer; Bayer; Eisai; Eisai; ipsen; Janssen Oncology; Janssen Oncology; Janssen Oncology; Pfizer; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; BMS; Ipsen; IPSEN; Janssen Oncology; MSD Oncology; Novartis AAA; Pfizer; Pfizer; Pfizer
 
Alessandra Mosca
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Ipsen; Janssen JJ; MSD; Pfizer
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Ipsen; Janssen J/J; MSD; Pfizer
 
Juan Carlos Vázquez Limón
Honoraria - Abbvie; Amgen; AstraZeneca; BMZ; GlaxoSmithKline; MSD; Novartis; Regeneron; Roche; Samsung
Consulting or Advisory Role - AstraZeneca; Janssen; MSD; Roche
Research Funding - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Regeneron; Roche; Samsung
Travel, Accommodations, Expenses - AstraZeneca; Janssen; MSD; Pfizer
 
Daniel Vaena
Honoraria - HMP; OncLive; Total Health Conferencing
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Cardinal Health; Curio/Vaniam Group; DAVA Pharmaceuticals; EMD Serono; Exelixis; Gilead Sciences; IntrinsiQ; MJH Life Sciences; Sanofi; Seagen
Research Funding - ALX Oncology (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Compugen (Inst); Exelixis (Inst); Merck (Inst); OBI Pharma (Inst); Roche/Genentech (Inst); Seagen (Inst); Tallac Therapeutics (Inst); Tizona Therapeutics, Inc. (Inst)
 
Christopher Wee
Consulting or Advisory Role - Alphasights; Alphasights; Aptitude Health; Bayer HealthCare Pharmacuticals; Capvision; ClarityCo; Curio Science; DocDelta; Janssen; MJH Life Sciences; The Dedham Group
Research Funding - Merck
 
Manuel Magallanes
Consulting or Advisory Role - Amgen; Asofarma; AstraZeneca; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Speakers' Bureau - Asofarma; AstraZeneca; Lilly; MSD; Pfizer; Roche
Research Funding - Bristol-Myers Squibb; Lilly; Merck; Roche
Travel, Accommodations, Expenses - Janssen; Merck; Novartis
 
Haixia Hu
Employment - MSD
 
Charles Schloss
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Christian Poehlein
Employment - Merck
Leadership - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Evan Yu
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Bristol Myers Squibb; Janssen; Loxo/Lilly; Merck; Oncternal Therapeutics
Research Funding - Bayer (Inst); Blue Earth Diagnostics (Inst); Dendreon (Inst); Lantheus Medical Imaging (Inst); Merck (Inst); Oncternal Therapeutics (Inst); Seagen (Inst); Tyra Biosciences (Inst)